Role of the Maisonneuve-Rosemont Hospital Foundation in the funding ecosystem
The Maisonneuve-Rosemont Hospital Foundation is a non-profit charitable foundation dedicated to supporting Maisonneuve-Rosemont Hospital (HMR) in Montréal. By mobilizing individuals, companies and partner foundations, it raises significant funds and channels them into hospital and research projects that improve patient care, accelerate innovation and strengthen health services for the large population served by HMR.
The Foundation focuses on two major areas of impact: transforming the future of care and building healthier communities. In practice, this translates into funding for cutting-edge research, new therapies, and improved patient pathways within and beyond the hospital.
Key funding themes and types of projects supported
On the research and innovation side, the Foundation supports projects such as cell and gene therapy, clinical research infrastructure and nephrology research. These initiatives aim to develop advanced treatments, expand access to stem cell transplants and improve outcomes for patients facing complex diseases, including cancer and severe kidney conditions.
Under its community and patient-support focus, the Foundation finances initiatives like Onco 360 (an oncology partner space for survivors and families), home nephrology care programs and the transcultural pediatric clinic, which helps overcome language and cultural barriers so that families fully understand their care. Funds are also directed to advanced medical equipment and the training of clinical teams in best practices and innovative techniques.
Beneficiaries and overall impact
The Foundation’s funding directly benefits HMR’s patients, clinical teams and researchers. Over 150 researchers working in cancer and immunology, kidney disease and vision health are supported through grants and project funding administered by the Foundation. The hospital serves roughly one in four Montrealers and one in ten patients in Québec, so improvements in equipment, facilities, and clinical programs have a broad regional impact.
Major donations highlighted on the site, such as contributions from the Sandra and Alain Bouchard Foundation, the Courtois Foundation, Suncor and the RBC Foundation, are earmarked for specific projects in research, equipment purchase and specialized clinics. This illustrates the Foundation’s role as a structured funding body that aggregates philanthropic capital and redistributes it strategically to priority projects at HMR.
Governance, campaigns and transparency
The Foundation regularly launches large-scale fundraising campaigns, including an ambitious multi‑year campaign detailed on the site. Campaign communications describe how contributions will be used: to offer care meeting the highest standards, accelerate research on still‑incurable diseases, train teams in advanced care techniques and acquire state-of-the-art equipment. This emphasis on clear objectives and tangible projects supports transparency and accountability toward donors and the wider community.